Trials / Conditions / Advanced Metastatic Cancer
Advanced Metastatic Cancer
3 registered clinical trials studyying Advanced Metastatic Cancer — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors NCT07424547 | Conjupro Biotherapeutics, Inc. | Phase 1 |
| Enrolling By Invitation | Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy NCT06506955 | Taiho Oncology, Inc. | Phase 2 / Phase 3 |
| Completed | Nivolumab With or Without Ipilimumab in Advanced Metastatic Cancer NCT03651271 | Parker Institute for Cancer Immunotherapy | Phase 2 |